RS20050752A - Kombinacija makrolida i lokalnog anestetika za tretman dermatoloških oboljenja - Google Patents

Kombinacija makrolida i lokalnog anestetika za tretman dermatoloških oboljenja

Info

Publication number
RS20050752A
RS20050752A YUP-2005/0752A YUP20050752A RS20050752A RS 20050752 A RS20050752 A RS 20050752A YU P20050752 A YUP20050752 A YU P20050752A RS 20050752 A RS20050752 A RS 20050752A
Authority
RS
Serbia
Prior art keywords
local anesthetic
macrolide
combination
treatment
immunomodulator
Prior art date
Application number
YUP-2005/0752A
Other languages
English (en)
Serbian (sr)
Inventor
Maximilian Grassberger
Stefan Hirsch
Nabila Sekkat
Carl Martin Weiss
Original Assignee
Novartis Ag.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag., filed Critical Novartis Ag.,
Publication of RS20050752A publication Critical patent/RS20050752A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YUP-2005/0752A 2003-04-04 2004-04-02 Kombinacija makrolida i lokalnog anestetika za tretman dermatoloških oboljenja RS20050752A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307869.8A GB0307869D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003515 WO2004087144A1 (en) 2003-04-04 2004-04-02 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases

Publications (1)

Publication Number Publication Date
RS20050752A true RS20050752A (sr) 2007-11-15

Family

ID=9956231

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0752A RS20050752A (sr) 2003-04-04 2004-04-02 Kombinacija makrolida i lokalnog anestetika za tretman dermatoloških oboljenja

Country Status (13)

Country Link
US (1) US20060110448A1 (https=)
EP (1) EP1613317A1 (https=)
JP (1) JP2006522061A (https=)
CN (1) CN1771036A (https=)
AU (1) AU2004226823A1 (https=)
BR (1) BRPI0409207A (https=)
CA (1) CA2521261A1 (https=)
GB (1) GB0307869D0 (https=)
IS (1) IS8106A (https=)
MX (1) MXPA05010709A (https=)
NO (1) NO20055137L (https=)
RS (1) RS20050752A (https=)
WO (1) WO2004087144A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
KR102141441B1 (ko) * 2018-06-28 2020-08-05 이환석 무출혈 무통필름
CN108853312B (zh) * 2018-09-25 2021-04-16 陕西天宇制药有限公司 聚桂醇外用凝胶及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB766245A (en) * 1954-09-03 1957-01-16 Lilly Co Eli Therapeutic preparations containing erythromycin
HU194493B (en) * 1985-11-27 1988-02-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
CN100335063C (zh) * 1994-10-26 2007-09-05 诺瓦蒂斯有限公司 药物组合物
CN1158258A (zh) * 1996-12-11 1997-09-03 李志辉 秦云创伤外用药
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US6120792A (en) * 1998-04-29 2000-09-19 Juni; Jack E. Medicated skin patch and method for its use
JP2001288086A (ja) * 1999-07-21 2001-10-16 Shoei:Kk 皮膚疾患の治療用又は予防用外用剤
JP2001288085A (ja) * 1999-07-21 2001-10-16 Shoei:Kk 乾癬の治療用又は予防用外用剤
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
WO2002062353A1 (en) * 2001-02-05 2002-08-15 Marie Madeline Wharton Composition containing sucrafate and a topical anesthetic for human and animals and method of use thereof
RU2195279C1 (ru) * 2001-07-10 2002-12-27 Тульский государственный университет Способ лечения отморожений
CN1189193C (zh) * 2001-09-10 2005-02-16 黄家伶 烧伤药膏
CN1197576C (zh) * 2002-08-30 2005-04-20 孙万一 治疗性病疣的药物及其制备方法

Also Published As

Publication number Publication date
CA2521261A1 (en) 2004-10-14
CN1771036A (zh) 2006-05-10
IS8106A (is) 2005-10-31
JP2006522061A (ja) 2006-09-28
AU2004226823A1 (en) 2004-10-14
NO20055137L (no) 2006-01-04
US20060110448A1 (en) 2006-05-25
GB0307869D0 (en) 2003-05-14
NO20055137D0 (no) 2005-11-02
MXPA05010709A (es) 2005-12-12
BRPI0409207A (pt) 2006-03-28
WO2004087144A1 (en) 2004-10-14
EP1613317A1 (en) 2006-01-11

Similar Documents

Publication Publication Date Title
RS20050739A (sr) Farmaceutska kompozicija koja obuhvata imunosupresant za upotrebu u lečenju oboljenja kože
CA2399971C (en) Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
JP2004521112A (ja) 関節痛治療薬を製造することへの神経毒性物質の使用
RS20050752A (sr) Kombinacija makrolida i lokalnog anestetika za tretman dermatoloških oboljenja
US20080132534A1 (en) Pharmaceutical composition comprising a macrolide immunomodulator
US20100190860A1 (en) Methods for selectively enhancing antinociceptive potency of local anesthetics
AU2004226822B2 (en) Pharmaceutical composition comprising a macrolide immunomodulator
AU2004226820B2 (en) Combination of a macrolide T-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease
CN100475199C (zh) 大环内酯t-细胞调节剂或免疫抑制剂与类视色素的协同组合
CA2521260A1 (en) Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials
CN104487051A (zh) 用于脊椎施用的可注射过饱和对乙酰氨基酚溶液